Agilent Technologies Inc.
Agilent Reports First-Quarter Fiscal Year 2024 Financial Results
Summary
Agilent Technologies, Inc. reported financial results for the first fiscal quarter of 2024. The company's revenue of $1.66 billion showed a 5.6% decline year-over-year. GAAP net income was $348 million with earnings per share (EPS) of $1.18, down 1% from the first quarter of 2023. Non-GAAP net income was $380 million with EPS of $1.29, down 6% from the previous year. The company maintained its full-year revenue outlook at $6.710 billion to $6.810 billion, with non-GAAP earnings guidance of $5.44 to $5.55 per share. Agilent's Life Sciences and Applied Markets Group and Diagnostics and Genomics Group reported declines in revenue, while the Agilent CrossLab Group saw an increase. The company also provided guidance for the second quarter with expected revenue between $1.560 billion and $1.590 billion and non-GAAP EPS between $1.17 and $1.20.
Profitelligence Alerts
Get alerts for A
Be first to know when Agilent Technologies Inc. files with the SEC.
Filing Categories
Exhibits (1)
Advertisement
About Agilent Technologies Inc.
Agilent Technologies Inc. is a global leader in the development and provision of life sciences, diagnostics, and applied chemical markets. Primarily focused on delivering superior analytical instruments, software, services, consumables, and reagents, the company plays a critical role in supporting the research needs of pharmaceutical, biotechnology, and government laboratories. Agilent's robust portfolio includes innovative solutions for genomics, proteomics, and metabolomics, aiding in critical areas such as disease research, food safety, and environmental analysis. Established in 1999 as a spin-off from Hewlett-Packard, the company leverages its heritage of technological innovation to enhance analytical capabilities for its clients. Agilent's significant contributions to health and safety applications underscore its importance in advancing scientific understanding and supporting public health initiatives worldwide.
Official SEC Documents
Advertisement